Omnicell Reports 7% Revenue Growth to $312.2 Million in Q2 2026

Omnicell, Inc. reported a significant increase in financial performance for the second quarter of 2026, with total revenues reaching $312.2 million, a 7% increase from $290.6 million in the same period last year. For the first half of 2026, revenues totaled $622.1 million, up 11% from $560.2 million in the first half of 2025. The growth was driven by a 7% increase in product revenues, which amounted to $175.1 million, and an 8% rise in service revenues, totaling $137.1 million. The company’s net income for the second quarter was $24.3 million, compared to $5.6 million in the prior year, resulting in a diluted earnings per share of $0.52, up from $0.12.

In terms of operational metrics, Omnicell's customer base and product adoption rates have shown positive trends. The company reported an increase in its installed customer base, which contributed to the growth in service revenues, particularly in technical services and SaaS offerings. The company’s international sales accounted for 10% of total revenues, reflecting a slight increase from 9% in the previous year. Omnicell's employee headcount stood at approximately 3,485 as of June 30, 2026, indicating a stable workforce to support its expanding operations.

The company also noted a decrease in total cost of revenues, which fell to $159.3 million from $162.9 million year-over-year, primarily due to a $14 million refund received for previously paid tariffs. This contributed to an increase in gross profit to $152.9 million, resulting in a gross margin of 49%, up from 44% in the prior year. Omnicell's operating expenses remained relatively stable, with total operating expenses increasing slightly to $120.5 million from $119.6 million, reflecting ongoing investments in research and development and administrative functions.

Looking ahead, Omnicell remains optimistic about its growth trajectory, driven by the increasing demand for automation in medication management solutions. The company is focused on expanding its product offerings and enhancing its service capabilities to meet the evolving needs of healthcare providers. The management anticipates that the challenges facing the healthcare industry, such as workforce shortages and rising operational costs, will drive further adoption of its solutions. The company has also secured a $350 million revolving credit facility to support its operational and strategic initiatives, ensuring sufficient liquidity for future growth opportunities.